LIFE SCIENCES & AI DRUG DISCOVERY

Accelerating First-in-Class Antibody Discovery with High-Fidelity Biological Data

How a global AI biotech company improved ML model accuracy and shortened R&D cycles using PatSnap's AI-extracted antibody sequence datasets.

Explore Now

The Challenge

A global AI-driven biotech company set out to develop advanced machine learning models to accelerate antibody discovery. However, progress was slowed by a critical data bottleneck.

Biological datasets required for model training were highly complex and fragmented across sources. Existing datasets lacked the consistency, validation, and structure required for both scientific research and AI model development. In addition, the organization needed to reconcile data requirements across multiple teams, including scientists, data engineers, and legal stakeholders. This created challenges in data ingestion, slowed target identification, and introduced potential intellectual property and compliance risks.

The Solution

PatSnap's proprietary hybrid data curation method utilize advanced OCR, NER, NOR and LLM technologies to extract antibody-antigen sequence pairings from patents in a cost-effective and scalable manner. Eureka delivered a Standardized Data Flat file solution for AI-driven drug discovery workflows.
The dataset provided a comprehensive and highly structured antibody sequence database covering global public antibody data, optimized for direct integration into machine learning pipelines. Key components included: deeply validated antibody–antigen (AB–AG) pairs, standardized epitope sequences mapped directly to their target antigens, comprehensive binding affinity metrics (IC50 and EC50 values), and pre-cleaned and normalized datasets ready for immediate ML ingestion. The standardized format enabled seamless collaboration across bioinformatics and antibody discovery teams while adhering to the FAIR standard.

The Impact

  • Improved Machine Learning Model Performance: High-fidelity, validated datasets significantly improved the accuracy and operational performance of the company's antibody discovery models.
  • Faster R&D Cycles: Dramatically shortened the antibody drug R&D cycle and reduced trial-and-error costs.
  • Compliance & IP Security: Eliminated intellectual property risks through strict compliance documentation.

Technical Implementation

Data Delivered

  • 240,000+ AB-AG pairs
  • 2,000+ standardized epitopes
  • 24,000+ affinity data points

Key Capabilities

  • Cross-species full coverage
  • Direct mapping to antigen sequences
  • FAIR standard compliance

Primary Use Cases

Antibody discovery, candidate selection, target identification, structural prediction, antibody design, binding validation.

Data Flatfile Dump (Standardized)

Case study summary

Industry
Fortune 500 | Smart Manufacturing
Customer type
Global smart manufacturing enterprise
Challenge
Multiple R&D centers worldwide operated in silos with fragmented IP systems, manual patent search and analysis, and no unified data foundation to support group-level decisions and collaboration.
PatSnap capabilities used
Global patent/literature/legal data via API, semantic search and AI reporting, deep integration with internal PLM/OA systems
Integration method
PatSnap Open Platform APIs were integrated into the customer's PLM, OA, and related systems to build a unified IP data layer and AI-powered workflows across the full R&D lifecycle.
Business impact
R&D teams improved patent search and analysis efficiency by 50%+, shortened product launch cycles, automated patent lifecycle management, and enabled group-level IP strategy and global collaboration.

PatSnap capabilities used

Through PatSnap Open Platform, the customer unified access to global patent, literature, and legal data via APIs, embedded semantic search and AI-powered classification/reporting, and deeply integrated these capabilities into internal PLM and OA systems to create an end-to-end IP data foundation.

Integration path

The project followed a centralized build approach: first unifying IP data sources via APIs, then embedding search and analytics into existing R&D workflows, and finally connecting multiple regional R&D centers so IP information flows in real time across project initiation, development, and risk control.

Related resources

FAQ

Why did this enterprise need a unified IP data foundation?
With R&D centers distributed across multiple regions, fragmented IP systems made it hard to manage and analyze patent data at a group level, slowing decisions and collaboration. A unified data foundation was required to support global strategy and AI-powered workflows.
What did PatSnap actually deliver in this project?
PatSnap delivered unified access to global patent, literature, and legal data via APIs, semantic search and AI reporting capabilities, and deep integration with the customer's PLM, OA, and IP management systems to support end-to-end workflows from search and analysis to risk monitoring.
What are the prerequisites for deploying a similar solution?
Typical prerequisites include mapping current IP and R&D workflows, identifying key systems such as PLM, OA, and IP management, and working with PatSnap to define data scope, security, and integration patterns, followed by phased PoCs and rollout.